24 Results for "

Levodopa

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "Levodopa" in MCE Product Catalog:

35
35 Publications Verification
Cat. No.: HY-N0304
CAS No.: 59-92-7
Synonyms: Levodopa; 3,4-Dihydroxyphenylalanine
L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
35
35 Publications Verification
Cat. No.: HY-N0304A
CAS No.: 63302-01-2
Synonyms: Levodopa sodium; 3,4-Dihydroxyphenylalanine sodium
L-DOPA (Levodopa) sodium is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA sodium can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA sodium has anti-allodynic effects, and can be used for Parkinson's disease research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0304R
CAS No.: 59-92-7
Synonyms: Levodopa (Standard); 3,4-Dihydroxyphenylalanine (Standard)
L-DOPA (Standard) is the analytical standard of L-DOPA. This product is intended for research and analytical applications. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18654
CAS No.: 1235318-89-4
Target:  

mGluR

Research Areas:  

Neurological Disease

ADX88178 is an orally active, blood-brain barrier-penetrant, selective positive allosteric modulator of mGluR4, with an EC50 of 3.5 nM against hmGluR4. ADX88178 modulates mGlu4 activity, enhances glutamate-mediated receptor activation, and increases the apparent affinity of glutamate for the receptor. ADX88178 reverses haloperidol-induced catalepsy, potentiates the effects of levodopa (L-DOPA) and quinpirole, but fails to alleviate established abnormal involuntary movements, does not exacerbate L-DOPA-induced dyskinesia, and does not affect forelimb akinesia when administered alone. ADX88178 can be used in research related to L-DOPA-induced dyskinesia and Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0304S2
CAS No.: 586971-29-1
L-DOPA- 13C is the 13C labeled L-DOPA . L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
Cat. No.: HY-14859
CAS No.: 872363-17-2
Purity:  99.90%
Synonyms: ADX48621
Target:  

mGluR

Research Areas:  

Neurological Disease

Dipraglurant (ADX48621) is a potent, selective, orally active and brain penetrant mGluR5 negative allosteric modulator (NAM), with an IC50 of 21 nM. Dipraglurant can reduce Levodopa-induced dyskinesia (LID) in vivo . Dipraglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-116016
CAS No.: 37178-37-3
Purity:  99.00%
Synonyms: L-DOPA ethyl ester; Levodopa ethyl ester
Research Areas:  

Neurological Disease

Etilevodopa (L-Dopa ethyl ester), an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine .
loading...
    loading...
Cat. No.: HY-W011963
CAS No.: 1421-65-4
Synonyms: Levodopa methylester hydrochloride
Melevodopa (Levodopa methylester) hydrochloride is an orally active methylated prodrug of Levodopa (HY-N0304), a dopamine precursor. When used in combination with Carbidopa (HY-B0311) in an effervescent tablet formulation, Melevodopa hydrochloride inhibits motor fluctuations in Parkinson's disease. Melevodopa hydrochloride suppresses subcutaneous tumor growth, pulmonary metastasis proliferation, and primary mass invasiveness of melanoma. Melevodopa hydrochloride induces lipid peroxidation by increasing malondialdehyde levels in melanoma and improves the survival rate of melanoma-bearing mice. Melevodopa hydrochloride can be used in research related to Parkinson's disease (with motor fluctuations) and melanoma .
loading...
    loading...
Cat. No.: HY-N0304S
CAS No.: 713140-75-1
Synonyms: Levodopa-d6; 3,4-Dihydroxyphenylalanine-d6
L-DOPA-d6 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
Cat. No.: HY-109131
CAS No.: 1907685-81-7
Purity:  95.91%
Synonyms: ABBV-951; Carbidopa 4′-monophosphate
Foscarbidopa (ABBV-951; Carbidopa 4′-monophosphate) is an inhibitory prodrug targeting peripheral aromatic L-amino acid decarboxylase. Foscarbidopa is hydrolyzed into Carbidopa (HY-B0311) by phosphatases in vivo to suppress peripheral metabolism of levodopa and elevate brain delivery of levodopa. Foscarbidopa can be used for the research of Parkinson’s disease and advanced Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-132392S
CAS No.: 53587-29-4
Purity:  98.80%
L-DOPA-2,5,6-d3 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain .
loading...
    loading...
Cat. No.: HY-N0304S1
CAS No.: 201417-12-1
Synonyms: Levodopa-13C6; 3,4-Dihydroxyphenylalanine-13C6
L-DOPA- 13C6 is the 13C-labled L-DOPA . L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
Cat. No.: HY-116016A
CAS No.: 39740-30-2
Purity:  99.40%
Synonyms: L-DOPA ethyl ester hydrochloride; Levodopa ethyl ester hydrochloride
Research Areas:  

Neurological Disease

Etilevodopa (L-Dopa ethyl ester) hydrochloride, an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine .
loading...
    loading...
Cat. No.: HY-CE01682
CAS No.: 945411-96-1
Synonyms: Levodopa-coenzyme A
Research Areas:  

Metabolic Disease

Levodopa-CoA (Levodopa-coenzyme A) is a coenzyme A derivative .
loading...
    loading...
Cat. No.: HY-116016AR
CAS No.: 39740-30-2
Synonyms: L-DOPA ethyl ester hydrochloride (Standard); Levodopa ethyl ester hydrochloride (Standard)
Etilevodopa (hydrochloride) (Standard) is the analytical standard of Etilevodopa (hydrochloride). This product is intended for research and analytical applications. Etilevodopa (L-Dopa ethyl ester) hydrochloride, an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine[1][2][3].
loading...
    loading...
Cat. No.: HY-122278
CAS No.: 7101-51-1
Synonyms: Levodopa methylester
Melevodopa (Levodopa methylester) is an orally active methylated prodrug of Levodopa (HY-N0304), a dopamine precursor. When used in combination with Carbidopa (HY-B0311) in an effervescent tablet formulation, Melevodopa inhibits motor fluctuations in Parkinson's disease. Melevodopa suppresses subcutaneous tumor growth, pulmonary metastasis proliferation, and primary mass invasiveness of melanoma. Melevodopa induces lipid peroxidation by increasing malondialdehyde levels in melanoma and improves the survival rate of melanoma-bearing mice. Melevodopa can be used in research related to Parkinson's disease (with motor fluctuations) and melanoma .
loading...
    loading...
Cat. No.: HY-116016R
CAS No.: 37178-37-3
Synonyms: L-DOPA ethyl ester (Standard); Levodopa ethyl ester (Standard)
Chlorbenside (Standard) is the analytical standard of Chlorbenside. This product is intended for research and analytical applications. Chlorbenside is an organochlorine pesticide. Chlorbenside targets organism such as mites and ticks and possesses efficient ovicidal and larvicidal activities .
loading...
    loading...
Cat. No.: HY-B0311D
CAS No.: 65132-60-7
Synonyms: (S)-(-)-Carbidopa hydrochloride
Research Areas:  

Cancer

Carbidopa hydrochloride ((S)-(-)-Carbidopa hydrochloride) is a drug used to inhibit Parkinson's disease, which has the activity of inhibiting the peripheral metabolism of levodopa. Carbidopa hydrochloride can increase the proportion of peripheral levodopa penetrating the blood-brain barrier, thereby enhancing its effect on the central nervous system. Carbidopa hydrochloride has also been found to be an aryl hydrocarbon receptor (AhR) ligand with anticancer activity, which can inhibit the growth of pancreatic cancer cells and tumors. The selective AhR regulation properties of carbidopa hydrochloride provide potential prospects for its clinical application .
loading...
    loading...
Cat. No.: HY-P11504
CAS No.: 3109821-26-0
Research Areas:  

Others

Fmoc-Lys-Gly-Dopa-OH is a tripeptide. Fmoc-Lys-Gly-Dopa-OH forms coacervates in aqueous solution via phase separation. Fmoc-Lys-Gly-Dopa-OH coacervates, with the assistance of Fe 3+, provide a viable material to engineer the surface of mammalian cells .
loading...
    loading...
Cat. No.: HY-N18690
CAS No.: 90064-10-1
Category:  

Extract

Target:  

Others

Mucuna pruriens extract, derived from the Mucuna pruriens plant, the primary active compound in Mucuna pruriens is L-dopa (levodopa), a precursor to the neurotransmitter dopamine, which contributes to its neuroprotective and mood-enhancing effects.
loading...
    loading...